Heartflow (HTFL) Stock Price, News & Analysis

Company Overview

HeartFlow, Inc. (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact. The output is intended to support diagnostic decision-making—helping to triage patients, reduce unnecessary invasive coronary angiography, and guide treatment planning such as the need for percutaneous coronary intervention or medical management. The company positions its technology as a tool for cardiology, radiology and emergency-department pathways where non-invasive assessment of coronary physiology can improve patient care.

The company works with hospitals, imaging centers and health systems and has expanded its commercial presence beyond the U.S. into multiple international markets. HeartFlow pursues collaborations with clinical research groups and payers to support adoption and reimbursement, and it emphasizes evidence from clinical studies demonstrating the clinical utility of physiology-based CT analysis. The business model centers on a software-as-a-service delivery of advanced image analysis and clinical reporting to support precision diagnostics in cardiovascular care.

Key Stats

• Today's Range: $33.80 to $35.30
• 50-Day Range: $28.93 to $37.64
• 52-Week Range: $26.56 to $39.24
• Volume: 140,586 shs
• Average Volume: 446,127 shs
• Market Capitalization: $2.87 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $36.60
• Consensus Rating: Moderate Buy

HTFL Stock Analysis - Frequently Asked Questions

How have HTFL shares performed this year?

Heartflow's stock was trading at $33.69 at the start of the year. Since then, HTFL stock has increased by 2.1% and is now trading at $34.41.

How were Heartflow's earnings last quarter?

Heartflow, Inc. (NASDAQ:HTFL) announced its earnings results on Friday, September, 19th. The company reported ($1.46) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by $1.26. The firm had revenue of $43.42 million for the quarter, compared to analysts' expectations of $43.20 million.

When did Heartflow IPO?

Heartflow (HTFL) raised $317 million in an initial public offering (IPO) on Friday, August 8th 2025. The company issued 16,666,667 shares at a price of $19.00 per share.

When did Heartflow's quiet period expire?

Heartflow's quiet period expired on Wednesday, September 17th. Heartflow had issued 16,666,667 shares in its IPO on August 8th. The total size of the offering was $316,666,673 based on an initial share price of $19.00. During Heartflow's quiet period, insiders and any underwriters that worked on the IPO were prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Heartflow?

Shares of HTFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 9/19/2025
• Today: 10/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:HTFL
• Previous Symbol: NASDAQ:HTFL
• CIK: 1464521
• Web: www.heartflow.com
• Phone: 650 241 1221
• Fax: N/A
• Employees: 699
• Year Founded: 2010

Price Target and Rating

• Average Price Target for Heartflow: $36.60
• High Price Target: $39.00
• Low Price Target: $35.00
• Potential Upside/Downside: +6.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $148.54 million
• Price / Sales: 19.32
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 83,396,000
• Free Float: N/A
• Market Cap: $2.87 billion
• Optionable: N/A
• Beta: N/A